 AnPac Bio-Medical Science Co., Ltd. AnPac Bio, the Company or we ANPC, a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today the allowance by the United States Patent and Trademark Office on May 6, 2020 of a new US patent for a novel medical device for disease detection utilizing integrated circuit technology. As a biotechnology company capable of multi-cancer screening and detection, AnPac Bio continues to focus on technical innovations and endeavors to increase its clinical sample size and data base in the field of cancer screening and detection, said Dr. Chris Yu, CEO and Chairman of AnPac Bio. 